StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific TTM Adjusted NOPAT (12-Month) by Quarter

TTM Adjusted NOPAT (12-Month) ($M)

QuarterlyAnnual

Thermo Fisher Scientific TTM Adjusted NOPAT (12-Month): $9,662M in Q3 2026.

Latest, Q3 2026
9,662
Period ended Sep 30, 2026
Change on a year earlier
–
History
6 quarters
Since Q4 2023
Sources
1
Q3 2026 Reconciliation of Financial Information

Where the Q3 2026 figure comes from

“Trailing twelve months' adjusted net income excluding net interest expense, net of tax benefit therefrom (non-GAAP measure) $ 8,737 $ 8,615 $ 8,963 $ 9,056 $ 9,336 $ 9,662”

Source: Q3 2026 Reconciliation of Financial Information ↗

Reported in IR Financial Reconciliation Package (Page 10 ROIC).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTTM Adjusted NOPAT (12-Month) ($M)Year on yearSource
Q3 2026Sep 30, 20269,662–Q3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 20269,336–Q3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 20269,056–Q3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 20258,963+4.0%Q3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 20248,615-1.4%Q3 2026 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 20238,737–Q3 2026 Reconciliation of Financial Information ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific TTM Adjusted NOPAT (12-Month) ($M), quarterly Q4 2023–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/roic-nopat-ttm-m

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.